Market Cap for Boston Scientific (BSX)
According to Boston Scientific's latest reported financial statements, the company's latest reported market cap is $93.81B USD. Market capitalization is the total dollar value of all outstanding shares — shares outstanding × stock price — and the standard measure of a company's equity value. On this page, historical market cap snaps filing-period share counts to closing prices on or before each statement date (not intraday tick data).
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingMarket CapSwitch metric
Latest period
$93.81B
YoY change
-40.0%
5Y CAGR
+7.0%
Peak year (2025)
$142.50B
Latest annual
$85.44B
Market Cap history chart for Boston Scientific (BSX) from 1992 to 2026
Market Cap history table for Boston Scientific (BSX) from 1992 to 2026
| Fiscal year | Period ended | Reported | Market Cap | YoY |
|---|---|---|---|---|
| 2026 | $85.44B | -40.0% | ||
| 2025 | $142.50B | +7.4% | ||
| 2024 | $132.72B | +56.9% | ||
| 2023 | $84.60B | +27.0% | ||
| 2022 | $66.61B | +9.4% | ||
| 2021 | $60.91B | +19.6% | ||
| 2020 | $50.93B | -20.2% | ||
| 2019 | $63.79B | +28.8% | ||
| 2018 | $49.53B | +43.4% | ||
| 2017 | $34.53B | +15.9% | ||
| 2016 | $29.79B | +20.4% | ||
| 2015 | $24.73B | +38.5% | ||
| 2014 | $17.86B | +10.8% | ||
| 2013 | $16.12B | +100.0% | ||
| 2012 | $8.06B | -0.6% | ||
| 2011 | $8.11B | -29.4% | ||
| 2010 | $11.49B | -15.3% | ||
| 2009 | $13.57B | +17.0% | ||
| 2008 | $11.60B | -32.9% | ||
| 2007 | $17.29B | -21.0% | ||
| 2006 | $21.88B | +6.7% | ||
| 2005 | $20.51B | -32.6% | ||
| 2004 | $30.45B | -1.7% | ||
| 2003 | $30.98B | +75.8% | ||
| 2002 | $17.62B | +75.9% | ||
| 2001 | $10.02B | +78.6% | ||
| 2000 | $5.61B | -37.8% | ||
| 1999 | $9.02B | -13.4% | ||
| 1998 | $10.41B | +13.5% | ||
| 1997 | $9.17B | -23.2% | ||
| 1996 | $11.94B | +31.7% | ||
| 1995 | $9.06B | +395.5% | ||
| 1994 | $1.83B | +48.1% | ||
| 1993 | $1.24B | -39.4% | ||
| 1992 | $2.04B | — |
Market Cap values are taken from Boston Scientific's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
2026's annual market cap for Boston Scientific (BSX) came in at $85.44B – plunged 40.0% year-over-year.
Looking at the 2021–2026 (5 years) stretch, Boston Scientific market cap compounded at +7.0% per year, with the latest reading among the more recent periods of the dataset.
Boston Scientific market cap peaked at $142.50B in 2025; the latest annual figure is $85.44B in 2026 (40.0% below peak).
The dataset's maximum market cap sits at $142.50B (2025); the minimum reading of $1.24B dates to 1993.
Boston Scientific (BSX) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $311.16B.
Boston Scientific Market Cap by Year
Boston Scientific Market Cap 2026: $85.44B
Boston Scientific market cap in 2026 was $85.44B, plunged 40.0% below 2025.
Boston Scientific Market Cap 2025: $142.50B
Boston Scientific market cap in 2025 was $142.50B, grew 7.4% from 2024. This figure represents the highest annual value in the available history.
Boston Scientific Market Cap 2024: $132.72B
Boston Scientific market cap in 2024 was $132.72B, surged 56.9% from 2023.
Boston Scientific Market Cap 2023: $84.60B
Boston Scientific market cap in 2023 was $84.60B, grew 27.0% from 2022.
Boston Scientific Market Cap 2022: $66.61B
Boston Scientific market cap in 2022 was $66.61B.
See more financial history for Boston Scientific (BSX).
Sector peers — Market Cap
Companies in the same sector as Boston Scientific, ranked by their latest market cap.
| Company | Market Cap | Sector |
|---|---|---|
| Eli Lilly and Company (LLY) | $825.77B | Healthcare |
| Johnson & Johnson (JNJ) | $548.34B | Healthcare |
| AbbVie Inc. (ABBV) | $349.67B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $332.91B | Healthcare |
| AstraZeneca PLC (AZN) | $289.41B | Healthcare |
| Merck & Co., Inc. (MRK) | $272.11B | Healthcare |
| Amgen Inc. (AMGN) | $183.05B | Healthcare |
| Novo Nordisk A/S (NVO) | $182.96B | Healthcare |
Frequently asked questions
What is Boston Scientific's market cap?
- Latest reported market cap for Boston Scientific (BSX) is $93.81B (period ending March 31, 2026).
How has Boston Scientific market cap changed year-over-year?
- Boston Scientific (BSX) market cap changed -40.0% year-over-year on the latest annual filing.
What is the long-term growth rate of Boston Scientific market cap?
- Boston Scientific (BSX) market cap compound annual growth rate is +7.0% over the most recent 5 years available.
When did Boston Scientific market cap hit its highest annual value?
- Boston Scientific market cap reached its highest annual value of $142.50B in 2025.
What was Boston Scientific market cap in 2025?
- Boston Scientific (BSX) market cap in 2025 was $142.50B.
What was Boston Scientific market cap in 2026?
- Boston Scientific (BSX) market cap in 2026 was $85.44B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
BSX Overview
Company profile, financial tools, and key metrics
BSX Revenue Counter
Earns $653.70 every second. See per minute, hour, and day.
BSX Earnings Counter
Earns $112.66 per second net profit. See per minute, hour, and day.
BSX Economic Scale
Exceeds Niger's GDP. Compare with world economies.
BSX What If Invested
What if you had invested $1,000? See historical returns from any date.
BSX How It Makes Money
Discover visual breakdown of $20.61B in revenue — where it comes from and where it goes.
BSX Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
BSX Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
BSX Daily Price Character
Balanced · 48.8% historical win rate (green days). Streaks & record days.
BSX Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.
BSX Stock Split History
2 splits on record. Dates, ratios, and cumulative multiple.